(Q48460372)

11 February 2018

title

Systemic anti-vascular endothelial growth factor therapies induce a painful sensory neuropathy. (English)

1 reference

11 February 2018

main subject

endothelium

0 references

author

Jean-Pierre Timmermans

8

1 reference

11 February 2018

Diether Lambrechts

11

Diether Lambrechts

1 reference

11 February 2018

10

Peter Carmeliet

1 reference

11 February 2018

4

Joke Dhondt

1 reference

11 February 2018

Koen Poesen

5

Koen Poesen

1 reference

11 February 2018

Eve Peeraer

2

Eve Peeraer

1 reference

11 February 2018

Rony Nuydens

3

Rony Nuydens

1 reference

11 February 2018

Theo Meert

9

Theo Meert

1 reference

11 February 2018

Isabel Pintelon

6

Isabel Pintelon

1 reference

11 February 2018

author name string

An Verheyen

1

1 reference

11 February 2018

Anneleen Daniels

7

1 reference

11 February 2018

language of work or name

English

0 references

publication date

25 June 2012

1 reference

11 February 2018

published in

Brain

1 reference

11 February 2018

volume

135

1 reference

11 February 2018

issue

Pt 9

1 reference

11 February 2018

page(s)

2629-2641

1 reference

11 February 2018

Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08.

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

Modulating molecular chaperone Hsp90 functions through reversible acetylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

Angiogenesis in life, disease and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

VEGF(165) promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

Drosophila histone deacetylase 6 protects dopaminergic neurons against {alpha}-synuclein toxicity by promoting inclusion formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

Paclitaxel directly binds to Bcl-2 and functionally mimics activity of Nur77

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

Managing patients treated with bevacizumab combination therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

HDAC6 is a microtubule-associated deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

Angiogenesis in brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

HDAC6 is required for epidermal growth factor-induced beta-catenin nuclear localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

Cancer pain and its impact on diagnosis, survival and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

Promotion of microtubule assembly in vitro by taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

Optic neuropathy in patients with glioblastoma receiving bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

Impaired function of HDAC6 slows down axonal growth and interferes with axon initial segment development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

HDAC6 modulates cell motility by altering the acetylation level of cortactin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS145

21 January 2018

Identifiers

DOI

10.1093/BRAIN/AWS145

1 reference

11 February 2018

1 reference

11 February 2018